Jack Kaye
CIK 1376099 · last filed 2026-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$772.1K
Companies
3
Total Filings
49
Lifetime Open-Market Net
-$1.94M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 4 of 5
49 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-01-30 | QURE | Grant (A) | +4,792 | $0 | EDGAR |
| 2017-01-31 | QURE | Grant (A) | — | $0 | EDGAR |
| 2015-06-18 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2013-09-09 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Gift (G) | −15,000 | -$137.0K | EDGAR |
| 2013-06-21 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Grant (A) | +15,000 | $0 | EDGAR |
| 2013-02-15 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Gift (G) | −10,000 | -$18.1K | EDGAR |
| 2012-06-22 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Grant (A) | +15,000 | $0 | EDGAR |
| 2012-01-04 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Gift (G) | −9,720 | -$25.8K | EDGAR |
| 2011-12-19 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Gift (G) | −86,680 | -$209.8K | EDGAR |
| 2011-07-13 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Grant (A) | +15,000 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.